Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
2021 · The Lancet HIV · 255 citations
https://doi.org/10.1016/s2352-3018(21)00103-x
A
Ane Ogbe
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
2.3K
Citations
19
h-index
26
i10-index
Ane Ogbe is an academic researcher from University of Oxford. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & HIV Research and Treatment. The author has an h-index of 19, co-authored 46 publications.
ORCID: 0000-0001-7774-7215Papers by this author
worksTwo doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
2021 · Nature Communications · 188 citations
https://doi.org/10.1038/s41467-021-25167-5
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study
2021 · The Lancet Microbe · 174 citations
https://doi.org/10.1016/s2666-5247(21)00275-5
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study
2021 · The Lancet Microbe · 174 citations
https://doi.org/10.1016/s2666-5247(21)00275-5
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
2022 · Nature Communications · 38 citations
https://doi.org/10.1038/s41467-022-28898-1
Immune checkpoint modulation enhances HIV-1 antibody induction
2020 · Nature Communications · 36 citations
https://doi.org/10.1038/s41467-020-14670-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat